Ms. Jin graduated from East China University of Political Science and Law with a LLB degree in 2002 and graduated from Shanghai Jiao Tong University with an MBA in Public Administration in 2008.

 

In 2022, Ms. Jin joined Jingtian & Gongcheng Shanghai office as a partner. Prior to this, Ms. Jin worked in Shanghai government for twelve years and worked in Jin Mao Law Firm as a partner for almost seven years.

 

Ms. Jin currently serves as a supervisor of Shanghai Training Association and legal advisor of Qingpu Branch of Shanghai Municipal Administration for Market Regulation.

 

Mr. Jin's main areas of practice are private equity and venture capital, fund formation and operation, investment and mergers and acquisitions, overseas investment, capital market, covering industries including healthcare, environmental protection, chips, real estate, etc., and her representative projects include providing legal services of mergers and acquisitions and private equity investment for SIIC Environment Holdings Ltd. (Stock Code: 00807.HK/BHK.SG), Weimob Inc. (Stock Code: 02013.HK), Mofang (China) Investment Co., Ltd., LYFE Capital, Cenova Capital, Sinopharm Capital, Guohe Capital, etc; she assisted a number of US dollar funds to apply for foreign investment equity investment pilot enterprises (QFLP) in Shanghai, including funds with market influence in the field of non-performing assets, infrastructure, long-term rental apartments, etc. In addition, based on her rich practical experience (FDI and ODI) in cross-border investment policies in China (Shanghai) Pilot Free Trade Zone, she and her team has provided cross-border restructuring services for red-chip enterprises such as Xpeng Inc. (Stock Code: 09868.HK), Weimob Inc. (Stock Code: 02013.HK), Genor Biopharma Holdings Ltd. (Stock Code: 06998.HK), Mininglamp Technology Group Limited, Sirnaomics Ltd. (Stock Code: 02257.HK).

 

Ms. Jin was admitted to PRC bar in 2006.

Education Background

Work Experiences

Professional Qualifications

PRC Lawyer’s License

Represented SIIC Environment Holdings Ltd. in industrial mergers and acquisitions of a number of environmental protection enterprises and sewage treatment plants. 

 

Represented Weimob Inc. (Stock Code: 02013.HK) in the acquisition of controlling interests of a number of companies.

 

Represented LYFE capital in financial investments in a dozen of healthcare enterprises.

 

Represented Apricot Capital in financial investments in a number of enterprises such as Suzhou Acumen Biomedical Technology Co., Ltd.

Provided overseas direct investment (ODI) legal services and some investor exit legal services for the establishment of red-chip structures of overseas listed enterprises such as Xpeng Inc. (Stock Code: 09868.HK), Weimob Inc. (Stock Code: 02013.HK), Genor Biopharma Holdings Ltd. (Stock Code: 06998.HK).

 

Provided fund establishment and project transaction full services for ALAN AMC to raise overseas funds to set up a QFLP pilot enterprise and invest in an office building project in Beijing.

 

Provided legal services for the establishment of QFLP pilot enterprises for Cenova Capital's US dollar fund.

 

Provided legal services for Orient International (a subsidiary of China Orient Asset) in setting up a non-perform

ing asset investment platform in Shanghai and to apply for a QFLP pilot.